Medifast closed at $13.15 on Nov 4, up 4.45% — matching its 52-week closing high. Volume of 127.1K shares was 0.94× its 20-day average (close to normal).
Split-adjusted performance: +14.2% over one month, +3.6% over six months, +10.7% over one year.
In the quarter ended Sep 30, 2026, revenue was $72.05M, down 19.4% from a year earlier, with a net margin of -24.3%.
Short interest was 1.2M shares at the Oct 15 settlement, up 9.9% from the prior report (11.6% of float, 11.4 days to cover).